{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:22:06Z","timestamp":1777044126182,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6860","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1038\/35102591","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:32:48Z","timestamp":1027657968000},"page":"212-216","source":"Crossref","is-referenced-by-count":1116,"title":["A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity"],"prefix":"10.1038","volume":"414","author":[{"given":"Sascha","family":"Weggen","sequence":"first","affiliation":[]},{"given":"Jason L.","family":"Eriksen","sequence":"additional","affiliation":[]},{"given":"Pritam","family":"Das","sequence":"additional","affiliation":[]},{"given":"Sarah A.","family":"Sagi","sequence":"additional","affiliation":[]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Claus U.","family":"Pietrzik","sequence":"additional","affiliation":[]},{"given":"Kirk A.","family":"Findlay","sequence":"additional","affiliation":[]},{"given":"Tawnya E.","family":"Smith","sequence":"additional","affiliation":[]},{"given":"Michael P.","family":"Murphy","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Bulter","sequence":"additional","affiliation":[]},{"given":"David E.","family":"Kang","sequence":"additional","affiliation":[]},{"given":"Numa","family":"Marquez-Sterling","sequence":"additional","affiliation":[]},{"given":"Todd E.","family":"Golde","sequence":"additional","affiliation":[]},{"given":"Edward H.","family":"Koo","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF35102591_CR1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama, H. et al. Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383\u2013421 (2000).","journal-title":"Neurobiol. Aging"},{"key":"BF35102591_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","volume":"47","author":"PL McGeer","year":"1996","unstructured":"McGeer, P. L., Schulzer, M. & McGeer, E. G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425\u2013432 (1996).","journal-title":"Neurology"},{"key":"BF35102591_CR3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1212\/WNL.43.8.1609","volume":"43","author":"J Rogers","year":"1993","unstructured":"Rogers, J. et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609\u20131611 (1993).","journal-title":"Neurology"},{"key":"BF35102591_CR4","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1212\/WNL.54.11.2066","volume":"54","author":"JC Anthony","year":"2000","unstructured":"Anthony, J. C. et al. Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study. Neurology 54, 2066\u20132071 (2000).","journal-title":"Neurology"},{"key":"BF35102591_CR5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.48.3.626","volume":"48","author":"WF Stewart","year":"1997","unstructured":"Stewart, W. F., Kawas, C., Corrada, M. & Metter, E. J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626\u2013632 (1997).","journal-title":"Neurology"},{"key":"BF35102591_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith, W. L., DeWitt, D. L. & Garavito, R. M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145\u2013182 (2000).","journal-title":"Annu. Rev. Biochem."},{"key":"BF35102591_CR7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0928-4257(98)80035-1","volume":"92","author":"SG Younkin","year":"1998","unstructured":"Younkin, S. G. The role of A\u03b242 in Alzheimer's disease. J. Physiol. Paris 92, 289\u2013292 (1998).","journal-title":"J. Physiol. Paris"},{"key":"BF35102591_CR8","doi-asserted-by":"crossref","first-page":"26277","DOI":"10.1074\/jbc.M002812200","volume":"275","author":"MP Murphy","year":"2000","unstructured":"Murphy, M. P. et al. Presenilin 1 regulates pharmacologically distinct \u03b3-secretase activities. Implications for the role of presenilin in \u03b3-secretase cleavage. J. Biol. Chem. 275, 26277\u201326284 (2000).","journal-title":"J. Biol. Chem."},{"key":"BF35102591_CR9","volume-title":"AHFS Drug Information","author":"GK McEvoy","year":"1998","unstructured":"McEvoy, G. K. AHFS Drug Information (American Society of Health-System Pharmacists, Bethesda, 1998)."},{"key":"BF35102591_CR10","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJM200006293422606","volume":"342","author":"PA Janne","year":"2000","unstructured":"Janne, P. A. & Mayer, R. J. Chemoprevention of colorectal cancer. N. Engl. J. Med. 342, 1960\u20131968 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BF35102591_CR11","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","volume":"20","author":"GP Lim","year":"2000","unstructured":"Lim, G. P. et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20, 5709\u20135714 (2000).","journal-title":"J. Neurosci."},{"key":"BF35102591_CR12","first-page":"2452","volume":"57","author":"GA Piazza","year":"1997","unstructured":"Piazza, G. A. et al. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res. 57, 2452\u20132459 (1997).","journal-title":"Cancer Res."},{"key":"BF35102591_CR13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9343(98)00091-6","volume":"104","author":"B Cryer","year":"1998","unstructured":"Cryer, B. & Feldman, M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. J. Med. 104, 413\u2013421 (1998).","journal-title":"Am. J. Med."},{"key":"BF35102591_CR14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1084\/jem.190.4.451","volume":"190","author":"X Zhang","year":"1999","unstructured":"Zhang, X., Morham, S. G., Langenbach, R. & Young, D. A. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J. Exp. Med. 190, 451\u2013459 (1999).","journal-title":"J. Exp. Med."},{"key":"BF35102591_CR15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0773.1978.tb02264.x","volume":"43","author":"MS Abdel-Halim","year":"1978","unstructured":"Abdel-Halim, M. S., Sjoquist, B. & Anggard, E. Inhibition of prostaglandin synthesis in rat brain. Acta Pharmacol. Toxicol. 43, 266\u2013272 (1978).","journal-title":"Acta Pharmacol. Toxicol."},{"key":"BF35102591_CR16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/35015085","volume":"405","author":"YM Li","year":"2000","unstructured":"Li, Y. M. et al. Photoactivated \u03b3-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689\u2013694 (2000).","journal-title":"Nature"},{"key":"BF35102591_CR17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/19083","volume":"398","author":"B De Strooper","year":"1999","unstructured":"De Strooper, B. et al. A presenilin-1-dependent \u03b3-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518\u2013522 (1999).","journal-title":"Nature"},{"key":"BF35102591_CR18","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1073\/pnas.131202798","volume":"98","author":"BK Hadland","year":"2001","unstructured":"Hadland, B. K. et al. \u03b3-secretase inhibitors repress thymocyte development. Proc. Natl Acad. Sci. USA 98, 7487\u20137491 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35102591_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1126\/science.2474201","volume":"245","author":"BA Yankner","year":"1989","unstructured":"Yankner, B. A. et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417\u2013420 (1989).","journal-title":"Science"},{"key":"BF35102591_CR20","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1523\/JNEUROSCI.16-21-06732.1996","volume":"16","author":"ML Oster-Granite","year":"1996","unstructured":"Oster-Granite, M. L., McPhie, D. L., Greenan, J. & Neve, R. L. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J. Neurosci. 16, 6732\u20136741 (1996).","journal-title":"J. Neurosci."},{"key":"BF35102591_CR21","doi-asserted-by":"crossref","first-page":"18851","DOI":"10.1074\/jbc.274.27.18851","volume":"274","author":"RG Perez","year":"1999","unstructured":"Perez, R. G. et al. Mutagenesis identifies new signals for \u03b2-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including A\u03b242. J. Biol. Chem. 274, 18851\u201318856 (1999).","journal-title":"J. Biol. Chem."},{"key":"BF35102591_CR22","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1073\/pnas.93.4.1683","volume":"93","author":"R Kopan","year":"1996","unstructured":"Kopan, R., Schroeter, E. H., Weintraub, H. & Nye, J. S. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc. Natl Acad. Sci. USA 93, 1683\u20131688 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35102591_CR23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/elps.1150180332","volume":"18","author":"J Wiltfang","year":"1997","unstructured":"Wiltfang, J. et al. Improved electrophoretic separation and immunoblotting of \u03b2-amyloid (A\u03b2) peptides 1\u201340, 1\u201342, and 1\u201343. Electrophoresis 18, 527\u2013532 (1997).","journal-title":"Electrophoresis"},{"key":"BF35102591_CR24","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu, W. Q. et al. Insulin-degrading enzyme regulates extracellular levels of amyloid \u03b2-protein by degradation. J. Biol. Chem. 273, 32730\u201332738 (1998).","journal-title":"J. Biol. Chem."},{"key":"BF35102591_CR25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/72237","volume":"6","author":"N Iwata","year":"2000","unstructured":"Iwata, N. et al. Identification of the major A\u03b21-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nature Med. 6, 143\u2013150 (2000).","journal-title":"Nature Med."},{"key":"BF35102591_CR26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","volume":"106","author":"DE Kang","year":"2000","unstructured":"Kang, D. E. et al. Modulation of amyloid \u03b2-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J. Clin. Invest. 106, 1159\u20131166 (2000).","journal-title":"J. Clin. Invest."},{"key":"BF35102591_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200017010-00001","volume":"17","author":"PL McGeer","year":"2000","unstructured":"McGeer, P. L. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease. Drugs Aging 17, 1\u201311 (2000).","journal-title":"Drugs Aging"},{"key":"BF35102591_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(99)00011-4","volume":"88","author":"H Yuan","year":"1999","unstructured":"Yuan, H. et al. Recombinant adenovirus is an appropriate vector for endocytotic protein trafficking studies in cultured neurons. J. Neurosci. Methods 88, 45\u201354 (1999).","journal-title":"J. Neurosci. Methods"},{"key":"BF35102591_CR29","doi-asserted-by":"crossref","first-page":"31894","DOI":"10.1074\/jbc.271.50.31894","volume":"271","author":"R Wang","year":"1996","unstructured":"Wang, R., Sweeney, D., Gandy, S. E. & Sisodia, S. S. The profile of soluble amyloid \u03b2 protein in cultured cell media. Detection and quantification of amyloid \u03b2 protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 271, 31894\u201331902 (1996).","journal-title":"J. Biol. Chem."},{"key":"BF35102591_CR30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","volume":"21","author":"T Kawarabayashi","year":"2001","unstructured":"Kawarabayashi, T. et al. Age-dependent changes in brain, CSF, and plasma amyloid (\u03b2) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21, 372\u2013381 (2001).","journal-title":"J. Neurosci."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/35102591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/35102591","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/35102591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T22:14:46Z","timestamp":1684275286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/35102591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":30,"journal-issue":{"issue":"6860","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["BF35102591"],"URL":"https:\/\/doi.org\/10.1038\/35102591","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1002456.20955","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}